Two-Year Hepatitis and HIV Seroprevalence in Samples of Patients Admitted to Primary Health Care Centers

Abstract

INTRODUCTION: Viral hepatitis and HIV are a global health problem causing acute and chronic infections. The aim of this study was to determine the HBsAg, Anti-HBs, Anti-HCV, anti-HAV IgG and Anti-HIV seropositivity rates in clinical samples sent from primary health care centers to Department of Van Public Health. METHODS: In this study, data obtained from the clinical HBsAg, anti-HBS, anti-HCV, HAV IgG and anti-HIV seroprevalence samples between January 2016 and January 2018 in Van province and its surrounding were retrospectively evaluated. Serum samples were analyzed by Chemiluminescent Microparticle İmmunoassay (CMIA) using Siemens (Advia CP, USA). Chi-square test was used for statistical evaluation of serological data. RESULTS: A total of 44509 patients were tested for HBsAg, 50183 patients for anti-HBs, 39552 patients for anti-HCV, 37671 patients for anti-HAV IgG and 35084 patients for anti-HIV tests. In this study, seropositivity rate was found as 1.66% in HBsAg, 30.6% in Anti-HBs, 0.27% in Anti-HCV, 48.67% in anti-HAV IgG and 0.005% in Anti-HIV. The highest anti-HBs seropositivity rate was found in patients who were under 15 years and between 15-24 years. DISCUSSION AND CONCLUSION: When compared with the literature, generally HbsAg, anti HBs, anti-HCV, HAV IgG and anti-HIV seroprevalence were found lower than published studies. The most important reason for the low seropositivity rates in this study is that the majority of donors can be considered as the formation of healthy individuals applying to primary health care centers to obtain a health report.

Keywords

• hepatitis b virus
• hepatitis c virus
• hepatitis a virus
• hiv seropositivity
• primary healthcare centers